CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise · Stock Option (right to buy) | −45,000 | 0 | ||
| 2021-07-02 | WEAVER GREGORY L Director | Option exercise · Stock Option (right to buy) | −70,000 | 0 | ||
| 2021-05-14 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-05-14 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-05-14 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2021-05-14 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (right to buy) | +850,000 | 850,000 | ||
| 2021-05-14 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (right to buy) | +1,900,000 | 1,900,000 | ||
| 2021-05-14 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-05-14 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-05-14 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-15 | Remmel H. Lawrence Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-05-15 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2020-05-15 | Steinhart Richard I Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-05-15 | Chen Shu-Chih Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-05-15 | Galli Stephen J Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-04-09 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2020-04-09 | Guse Kyle CFO, Gen Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +395,000 | 395,000 | ||
| 2020-04-09 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2020-04-09 | QUAY STEVEN C President & CEO | Grant or award · Stock Option (Right to Buy) | +1,305,000 | 1,305,000 | ||
| 2019-05-17 | WEAVER GREGORY L Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 |
Page 4 of 9 · 168 trades